Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Sarepta Therapeutics discloses in regulatory filing that the buyer of its Rare Pediatric Disease Priority Review Voucher was Gilead Sciences (GILD) (28.28)<em>See 07:03 for original mention of the transaction</em></td> </tr></table>"